Fact CheckerSign in

NCT05714839RecruitingPhase 1/2

A study to investigate the safety and clinical activity of belantamab for the treatment of multiple myeloma when used as monotherapy and in combination treatments.

Source: EU CTIS (euclinicaltrials.eu) · Last updated 1 Oct 2026

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
22 (estimated)
First submitted
9 Jan 2023
Start date
13 Dec 2023
Lead sponsor
Glaxosmithkline Research & Development Limited
NCT number
NCT05714839
EU CT number
2022-501941-63-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 22
  • 18 sites in 6 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (18)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gemeinschaftspraxis Haematologie Onkologie
Coordinator of this site? Confirm its status
DresdenGermanyNot yet recruiting
University Medical Center Hamburg-Eppendorf
Coordinator of this site? Confirm its status
HamburgGermanyNot yet recruiting
Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
Coordinator of this site? Confirm its status
MunichGermanyNot yet recruiting
Klinikum Oldenburg Aor
Coordinator of this site? Confirm its status
OldenburgGermanyNot yet recruiting
Universitaetsklinikum Wuerzburg AöR
Coordinator of this site? Confirm its status
WuerzburgGermanyNot yet recruiting
HUS-Yhtymae
Coordinator of this site? Confirm its status
HelsinkiFinlandRecruiting
Kuopio University Hospital
Coordinator of this site? Confirm its status
KuopioFinlandRecruiting
Tampere University Hospital
Coordinator of this site? Confirm its status
TampereFinlandRecruiting
Turku University Hospital
Coordinator of this site? Confirm its status
TurkuFinlandRecruiting
General Hospital of Athens - Alexandra
Coordinator of this site? Confirm its status
AthensGreeceNot yet recruiting
Athens Medical Center S.A.
Coordinator of this site? Confirm its status
ThessalonikiGreeceNot yet recruiting
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Coordinator of this site? Confirm its status
BolognaItalyNot yet recruiting
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coordinator of this site? Confirm its status
RomeItalyNot yet recruiting
Uniwersytecki Szpital Kliniczny nr 4 w Lublinie
Coordinator of this site? Confirm its status
LublinPolandRecruiting
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie
Coordinator of this site? Confirm its status
LublinPolandRecruiting
Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu
Coordinator of this site? Confirm its status
WroclawPolandRecruiting
Karolinska University Hospital
Coordinator of this site? Confirm its status
HuddingeSwedenNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.